No Detail Found!

Frequency of hypokalemia, clinical implications and risk factors in patients of covid-19

Author(s)
Sarmad Zahoor Mayo Hospital, Lahore, Pakistan
Uzma Malik Mayo Hospital, Lahore, Pakistan
Malik Muhammad Atif Mayo Hospital, Lahore, Pakistan
Sadia Asif Mayo Hospital, Lahore, Pakistan
Aleena Khan Mayo Hospital, Lahore, Pakistan
Sumera Hanif Mayo Hospital, Lahore, Pakistan
Ibrar Rafique Health Research Institute, National Institutes of Health, Islamabad, Pakistan
Muhammad Arif Nadeem Saqib Department of Medical Lab Technology National Skills University, Islamabad. Pakistan
Abstract
Objective: To determine the frequency of hypokalemia among COVID-19 patients and assess its impact on the patients management. Study type, settings & duration: It was a cross-sectional study conducted at Mayo Hospital, Lahore from July 2020 to January 2021. Methodology: A total of 212 SARS-COV-2 positive patients who had developed severe disease were enrolled. Based on the level of potassium, the patients were classified as mild, moderate and severe hypokalemia cases. Data was collected using a structured questionnaire including demography, clinical presentations and medication including use of anticoagulant and steroids. Results: Of the total 210, 46 (21.9%) patients had hypokalemia and among them 23 (11%) showed mild, 17 (8.1%) moderate and 6 (2.9%) severe hypokalemia. Out of 210, 17 (23.9%) patients were treated with hydrocortisone, 11 (17.4%) with methylprednisolone and 18 (23.3%) with dexamethasone and no significant difference was seen in development of hypokalemia (p =0.630). Similarly, 39 (21.4%) patients were given enoxaparin and 7 (24.1%) were given heparin, but no significant association was found between the type of anticoagulant being given and hypokalemia (p =0.754). No significant difference was observed with respect to gender in the development of hypokalemia (p =0.782). Conclusion: This study showed that hypokalemia was a significant clinical manifestation among SARS-COV-2 patients. Further it was noted that treatment regime used for COVID-19 management and gender of the patients are not a risk factor for developing the hypokalemia.
Publication Details
Page(s) 148-152
DOI DOI not available
Published Journal: Pakistan Journal of Medical Research, Volume: 62, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Steroids, hypokalemia, anticoagulant., Severe COVID-19
0

Citations

0

Downloads

43

Views